End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
99.78 CHF | -1.89% |
|
-5.56% | +8.46% |
04:11pm | Dsm-firmenich sees boost as weight-loss drugs spur healthier choices | RE |
Jun. 03 | Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft... | ![]() |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 58.65 and 33.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.46% | 28.61B | - | ||
+13.92% | 893B | D+ | ||
+3.63% | 248B | - | C | |
+0.35% | 136B | B- | ||
+68.63% | 96.68B | B+ | ||
-8.47% | 71.74B | B | ||
-7.67% | 55.81B | C+ | ||
+34.39% | 35.41B | A | ||
-41.28% | 30.22B | - | - | |
+70.49% | 29.76B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DSFIR Stock
- Ratings Danube AG